A macrophage sterol-responsive network linked to atherogenesis

Cell Metab. 2010 Feb 3;11(2):125-35. doi: 10.1016/j.cmet.2010.01.003.

Abstract

Cholesteryl ester accumulation by macrophages is a critical early event in atherogenesis. To test the hypothesis that sterol loading promotes foam cell formation and vascular disease by perturbing a network of interacting proteins, we used a global approach to identify proteins that are differentially expressed when macrophages are loaded with cholesterol in vivo. Our analysis revealed a sterol-responsive network that is highly enriched in proteins with known physical interactions, established roles in vesicular transport, and demonstrated atherosclerotic phenotypes in mice. Pharmacologic intervention with a statin or rosiglitazone and use of mice deficient in LDL receptor or apolipoprotein E implicated the network in atherosclerosis. Biochemical fractionation revealed that most of the sterol-responsive proteins resided in microvesicles, providing a physical basis for the network's functional and biochemical properties. These observations identify a highly integrated network of proteins whose expression is influenced by environmental, genetic, and pharmacological factors implicated in atherogenesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism
  • Atherosclerosis / metabolism*
  • Foam Cells / metabolism*
  • Gene Expression Regulation
  • Hypoglycemic Agents / pharmacology
  • Hypolipidemic Agents / pharmacology
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Proteins / analysis
  • Proteins / genetics
  • Proteins / metabolism*
  • Receptors, LDL / genetics
  • Receptors, LDL / metabolism
  • Rosiglitazone
  • Simvastatin / pharmacology
  • Sterols / metabolism*
  • Thiazolidinediones / pharmacology

Substances

  • Apolipoproteins E
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Proteins
  • Receptors, LDL
  • Sterols
  • Thiazolidinediones
  • Rosiglitazone
  • Simvastatin